James Willig

James Willig

Auto-generated profile, based on publicly available information

James Willig

Division of Infectious Disease Heersink School of Medicine University of Alabama at Birmingham Birmingham, AL United States

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2021 in Journal of Clinical and Translational Science
Verified
Journal Article
Open access
PDF file
JWJames H. Willig
James H. Willig
JCJennifer Croker
Jennifer Croker
LMLisa McCormick
Lisa McCormick
MNMeena Nabavi
Meena Nabavi
JWJeremey Walker
Jeremey Walker
DRDavid Redden
David Redden
Leveraging elements of game design and theories of human motivation, gamification provides a variety of techniques to engage learners in novel ways. Our Clinical and Translational Science Award created the software platform (Kaizen-Education©) to deliver gamified educational content in 2012. Here, we explore two novel use cases of this platform to provide practical insights for leveraging these methods in educational settings: (1) national training in rigor, reproducibility, and transparency and (2) attainment of learner competency (n = 7) as a gauge of curricular effectiveness across Master of Public Health degree tracks (n = 5). Data were captured in real time during player interaction with Kaizen-Education© to provide descriptive analyses of player engagement in both implementation examples. We then assessed item analysis to assess knowledge gain and competency attainment. We have just begun to leverage the potential for gamification to engage learners, enhance knowledge acquisition, and document completion of training, across various learning environments. We encourage a systematic approach to gamification applying insights from self-determination theory to learners and learning environments, a methodical approach to game design and rigorous analysis after implementation to generate evidence-based insights to maximize educational return for time invested.

7 March 2017 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
JCJeffrey R. Curtis
Jeffrey R. Curtis
LCLang Chen
Lang Chen
PHPhillip Higginbotham
Phillip Higginbotham
WNW. Benjamin Nowell
W. Benjamin Nowell
RGRonit Gal-Levy
Ronit Gal-Levy
RSRoee Sa’adon
Roee Sa’adon
Social media may complement traditional data sources to answer comparative effectiveness/safety questions after medication licensure. The Treato platform was used to analyze all publicly available social media data including Facebook, blogs, and discussion boards for posts mentioning inflammatory arthritis (e.g. rheumatoid, psoriatic). Safety events were self-reported by patients and mapped to medical ontologies, resolving synonyms. Disease and symptom-related treatment indications were manually redacted. The units of analysis were unique terms in posts. Pre-specified conditions (e.g. herpes zoster (HZ)) were selected based upon safety signals from clinical trials and reported as pairwise odds ratios (ORs); drugs were compared with Fisher’s exact test. Empirically identified events were analyzed using disproportionality analysis and reported as relative reporting ratios (RRRs). The accuracy of a natural language processing (NLP) classifier to identify cases of shingles associated with arthritis medications was assessed. As of October 2015, there were 785,656 arthritis-related posts. Posts were predominantly US posts (75%) from patient authors (87%) under 40 years of age (61%). For HZ posts (n = 1815), ORs were significantly increased with tofacitinib versus other rheumatoid arthritis therapies. ORs for mentions of perforated bowel (n = 13) were higher with tocilizumab versus other therapies. RRRs associated with tofacitinib were highest in conditions related to baldness and hair regrowth, infections and cancer. The NLP classifier had a positive predictive value of 91% to identify HZ. There was a threefold increase in posts following television direct-to-consumer advertisement (p = 0.04); posts expressing medication safety concerns were significantly more frequent than favorable posts. Social media is a challenging yet promising data source that may complement traditional approaches for comparative effectiveness research for new medications.

1 January 2010 in AIDS Patient Care and STDs
Verified
Journal Article
Open access
CBCynthia W. Baffi
Cynthia W. Baffi
IAInmaculada Aban
Inmaculada Aban
JWJames H. Willig
James H. Willig
MAMayank Agrawal
Mayank Agrawal
MMMichael J. Mugavero
Michael J. Mugavero
LBLaura H. Bachmann
Laura H. Bachmann
Syphilis outbreaks in the United States have been reported since 2000 with highest rates in the South and many cases among HIV-infected individuals. We evaluated incident syphilis cases and concurrent gonorrhea and chlamydia screening at a southern HIV clinic. A retrospective cohort study included HIV-infected patients with at least one reactive plasma reagin (test for serum reagin antibodies to cardiolipin-cholesterol-lecithin antigen) and primary care visit from July 2004 to June 2007. Primary, secondary, and early latent syphilis cases were identified as incident syphilis and evaluation for gonorrhea and chlamydia within 1 month were described. Logistic regression was performed to determine factors associated with incident syphilis. Among 1544 patients, 40 incident syphilis cases were identified (5 primary, 29 secondary, and 6 early latent). The majority of patients were not virologically suppressed and only 25% had gonorrhea and chlamydia testing. In adjusted analyses, younger age (0.57 per 10 years, 95% confidence interval [CI] 0.41–0.80) and minority race (2.26, 95% CI 1.12–4.59) were associated with incident syphilis. Among 40 incident syphilis cases, only 1 in 4 were further tested for gonorrhea and chlamydia. These low rates are concerning as concurrent sexually transmitted infections (STIs) increase risk for HIV transmission. HIV care provider education with emphasis on STI testing in the setting of incident syphilis is key in prevention.

1 May 2023 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
JCJeffrey R Curtis
Jeffrey R Curtis
JWJames Willig
James Willig
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Not required for Research Letters

15 August 2023 in JMIR Research Protocols
Verified
Journal Article
Open access
KGKelly W Gagnon
Kelly W Gagnon
SBStefan Baral
Stefan Baral
DLDustin M Long
Dustin M Long
AGAlfredo L Guzman
Alfredo L Guzman
BJBernadette Johnson
Bernadette Johnson
EEEllen Eaton
Ellen Eaton
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The syndemic of mental health (MH) and substance use disorders (SUDs) are common among persons living with HIV (PLWH) and jeopardize HIV treatment adherence, engagement in care, and viral load suppression. Electronic patient reported outcomes (ePROs), conducted via tablet or computer, and telemedicine are evidence- and technology-based interventions that have been used to successfully increase screening and treatment, respectively, a model that holds promise for PLWH. To date, there has been no guidance on how to implement ePROs and telemedicine into practice even though it is well-known that these evidence-based tools improve diagnosis and access to care. Objective: To address this, we are conducting a multicomponent intervention for PLWH, delivery of HIV services and Telemedicine through Effective ePROs (+STEP), to increase screening and treatment of MH and SUD in Ryan White HIV/AIDS Program (RWHAP)-funded clinics in Alabama. Methods: The Aims of this intervention are to: Aim 1) Conduct a needs assessment and implement +STEP to improve diagnosis and treatment of mental health (MH) and SUD at RWHAP clinics in Alabama; Aim 2) Describe implementation strategies that address barriers to uptake of +STEP in RWHAP clinics. We will conduct qualitative interviews in years 1 (early implementation), 2 (scale up), and 4 (maintenance) with patients and stakeholders (clinicians, staff) to evaluate barriers, facilitators, and implementation strategies. Results will enable us to modify strategies to enhance +STEP penetrance over time and inform the implementation blueprint, which we will develop for both RWHAP clinics in AL and future sites; Aim 3) Measure the impact of implementing +STEP on diagnoses, referrals, and healthcare utilization related to MH, SUD, and HIV by comparing clinical outcomes from patients receiving these interventions (ePROs, telemedicine) with historical controls. Results: The results of this study will provide a foundation for future research expanding access to ePROs for improved diagnosis linked to telemedicine access to accelerate patients along the continuum of care from MH and/or SUD diagnosis to treatment. Conclusions: Achieving the end of the HIV epidemic in the United States necessitates programs that accelerate movement across the MH and SUD care continuum from diagnosis to treatment for PLWH. Scaling these services represents a path towards improved treatment outcomes with both individual health and population level prevention benefits of sustained HIV viral suppression in the era of Undetectable = Untransmittable (U=U). Our study will address this evidence gap through the evaluation of implementation of +STEP to establish necessary systems and processes to screen, identify, and better treat substance use and mental health for people living with HIV.

20 November 2014 in International Journal of STD & AIDS
Verified
Journal Article
Closed access
RMRiddhi A Modi
Riddhi A Modi
GMGerald McGwin
Gerald McGwin
AWAndrew O Westfall
Andrew O Westfall
DPDeon W Powell
Deon W Powell
GBGreer A Burkholder
Greer A Burkholder
JWJames H Willig
James H Willig
The purpose of this study was to explore factors associated with venous thromboembolism (VTE) among a cohort of HIV-infected patients and to describe early outcomes of warfarin anticoagulation therapy treated in a pharmacist-based anticoagulation clinic (ACC). A nested case-control study was conducted using the University of Alabama at Birmingham 1917 HIV Clinic Cohort. Conditional logistic regression was used to estimate factors associated with VTE. Among HIV-infected VTE cases, ACC-managed patients were compared to primary care provider (PCP)-managed patients to determine Time within Therapeutic INR Range (TTR). CD4 < 200 cells/µl (OR = 4.50; 95% CI = 1.52, 13.37; p = 0.007) and prior surgical procedures (13.20; 1.56; 111.4; p = 0.018) demonstrated positive associations with VTE, whereas longer HIV duration demonstrated a negative association (0.87; 0.78, 0.98; p = 0.019). TTR was 56.2% among ACC-managed patients compared to 30.5% of PCP-managed patients (p = 0.174). Overall, prior surgical procedures and low CD4 count were associated with an increased risk of VTE among HIV-infected patients. Despite small sample size, patients managed in ACC tend to achieve greater proportion of TTR compared to those managed by PCPs, suggesting that this model of therapy may provide additional benefits to HIV-infected patients.